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Fluorescent proteinsIn the present study, detailed information is presented on the hetero-dimerization of the serotonin 5-HT2A
receptor and the dopamine D2 receptor. Biophysical approaches (ﬂuorescence spectroscopy as well as
ﬂuorescence lifetimemicroscopy) were used to determine the degree of ﬂuorescence resonance energy transfer
(FRET)between cyanand yellowﬂuorescent protein labeled receptor variants co-expressed inhumanembryonic
kidney 293 cells (HEK293). Recorded data demonstrate the existence of energy transfer between the wild-type
forms of 5-HT2AR and D2R, pointing toward the formation of hetero-5-HT2AR/D2R dimers and homo-5-HT2AR/5-
HT2AR dimers. Moreover, the present study investigates the role of speciﬁc motifs (one containing adjacent
arginine residues (217RRRRKR222) in the third intracellular loop (ic3) of D2R, and the other consisting of acidic
glutamate residues (454EE455) in the C-tail of (5-HT2AR) in the formation of noncovalent complexes between
these receptors. Our results suggest that these regions of 5-HT2AR and D2R may be involved in the interaction
between these twoproteins. On the other hand, the above-mentionedmotifs do not play an important role in the
homo-dimerization of these receptors. Furthermore, we estimated the inﬂuence of speciﬁc receptor ligands on
the dimerization processes. Agonists (DOI and quinpirole) and antagonists (ketanserin and butaclamol) cause
different effects on FRET efﬁciency depending on whether homo- or hetero-complexes are present. These data
may have therapeutic implications, since (using the immunoﬂuorescence double labeling protocols) the co-
localization of these two receptors was demonstrated in the medial prefrontal cortex and pars reticulate of the
substantia nigra of the rat brain.llow ﬂuorescent protein; FRET,
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In recent years, various evidence points to the existence of both
homo-dimers, hetero-dimers or higher-order oligomers of G protein-
coupled receptors (GPCRs, also known as heptahelical receptors) on the
plasma membrane [1–4]. The capacity of these plasma membrane
receptors to interact with other GPCRs superfamily members is
important for their function and biogenesis [5–8]. The association of
these proteins plays a key role in processes such as receptormaturation,protein folding, cell surface delivery [9–13] andGprotein binding [14–18]
as well as receptor activation and desensitization [11,19–21]. Moreover,
oligomerization of GPCRs is essential because the formation of unique
multi-protein complexes may lead to an alteration in signaling (interac-
tions between different classes of GPCRs point to a new level ofmolecular
cross-talk) and drug speciﬁcity [22–25]. Thus, understanding the
structuralmechanisms involved in receptor association and identiﬁcation
of the dimer interface is of fundamental importance.
Currently, data regarding when and how GPCRs dimerization
occurs remains limited. Several studies suggest that ligand binding
regulates dimer formation, either by promoting [26,27] or inhibiting
[28] dimerization. On the other hand, many other studies have shown
that homo- and hetero-dimerization are a constitutive phenomenon
and may be initiated during protein synthesis in the endoplasmic
reticulum [12,13,29,30]. The outcomes are equivocal probably
because different methods are often applied to understanding
protein–protein interactions.
The mechanism of intermolecular interactions involved in the
formation of dimers between receptors is still unknown. The precise
role of speciﬁc regions of receptor molecule(s) in the dimerization
process has not yet been elucidated. However, several models have
been described. Data indicate that covalent bonds (i.e., disulﬁde bonds
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extracellular domains of the receptor [26,31,32]. Alternatively,
interactions between the intracellular domain (i.e., a coiled-coil
interaction within the C-tail of the gamma-aminobutyric acid
(GABA)B receptor) are engaged in the process [33]. Interactions
between the transmembrane domains (i.e., hydrophobic interactions
detected for the dopamine D2 receptors (D2R)) are also suggested as a
potential mechanism by which GPCRs associate with one another
[17,34–39]. However, the interaction between transmembrane
domains is not the only point of contact and a combination of these
mechanisms likely plays a role in GPCRs oligomerization.
Moreover, electrostatic interactionsare also consideredaseffectively
engaged in the formation of complexes between proteins. Electrostatic
interactions may occur between characteristic epitopes; one epitope
containingmainly two ormore adjacent arginine residues and the other
epitope consisting of acidic (two or more adjacent aspartate or
glutamate) residues or/and a phosphorylated residue [40–42]. In a
previous study,we showed that anelectrostatic interactionsbetweenan
arginine-rich epitope from the third intracellular loop (ic3) of D2R
(217RRRRKR222) and two adjacent glutamate residues from the C-
terminus of the dopamine D1 receptor (D1R, 404EE405) participate in
hetero-dimerization between D1R and D2R [43]. Moreover, the role of
arginine residues within the ic3 of D2R in the formation of noncovalent
complexes between other GPCRs (D2R and the adenosine A2A receptor
and D2R and the cannabinoid CB1 receptor) has been highlighted in
previous studies [44,45]. A similar interaction has also been shown for
hetero-dimers of D1R and the ionotropic N-methyl-D-aspartic acid
(NMDA) receptor [46,47].
The widespread biological action of the serotonin (5-hydroxytrypta-
mine or 5-HT) and dopamine are mediated by two classes of membrane
receptors, including the serotonin 5-HT2A receptor (5-HT2AR) and
dopamine receptor (D2R). Both 5-HT2AR and D2R belong to the GPCRs
superfamily and play essential roles in neurotransmission [48,49].
Although these proteins are representative of distinct classes of GPCRs,
their interaction may be signiﬁcant. Alterations in either serotonin or
dopamine neurotransmission have been implicated in many human
neurological and psychiatric disorders, including depression, anxiety and
schizophrenia [50]. Both D2R and 5-HT2AR arewell-established targets of
various pharmacological compounds used to treat some of these
pathologies (in addition, second generation anti-psychotic agents have
afﬁnity for both of these receptors) [51]. Therefore, a detailed
understanding of the dimerization processes is very important in terms
of drugdiscovery, because it provides anopportunity to steer this process
towards new and potentially more effective therapeutics.
Identifying whether a hetero-interaction between 5-HT2AR and D2R
exists is very important. A hetero-dimerizationmay alter the potency of
ligands as well as therapeutic compounds. The existence of a hetero-
interaction is especially promising since hetero-dimers can be formed
only on neurons expressing both 5-HT2AR and D2R. Therefore, a higher
selectivity of the appropriate compoundsmay be achieved. Importantly,
we determine the inﬂuence of 5-HT2AR and D2R speciﬁc ligands
(agonists and antagonists) on the dimerization process.
Measurement of ﬂuorescence resonance energy transfer (FRET)
phenomenon which occurs between ﬂuorescently tagged receptors is
consideredaveryuseful tool [52–54], since it allows to study thephysical
interactions between receptor proteins either in a single cell or in
population of living cells. FRET is observed between a ﬂuorescent donor
and an acceptor chromophore when they are located within 100 Å of
each other and are arranged properly in terms of their transition dipole
moments [55]. Here, we use FRET to monitor protein dimer formation
between 5-HT2AR and D2R. We labeled 5-HT2AR and D2R with cyan
ﬂuorescentprotein (CFP, theﬂuorescence donor) and yellowﬂuorescent
protein (YFP, the ﬂuorescence acceptor) and expressed the receptors in
human embryonic kidney (HEK) 293 cells to address the question of
whether D2R and 5-HT2AR physically interact. Furthermore, in the
present study we investigate the potential role of amino acid residueslocated in characteristic epitopes in the ic3 (217RRRRKR222) of D2R and
in the C-terminus (454EE455) of 5-HT2AR in the interaction and dimer
formation of these receptors.
2. Materials and methods
2.1. Materials
All molecular biology reagents were obtained from Fermentas
(Vilnius, Lithuania). Oligonucleotides were synthesized by IBB PAN
(Warsaw, Poland). The pECFP-N1 and pEYFP-N1 vectors were purchased
from BD Biosciences, Clontech (Palo Alto, CA, USA). The pcDNA3.1(+)
plasmids encoding human 5-HT2AR and the human D2R proteins were
obtained from the UMR cDNA Resource Center (University of Missouri-
Rolla, MO, USA). Escherichia coli DH5α (Dam+) was purchased from
Novagen. HEK 293 cells were obtained from the American Type Culture
Collection (Manassas, VA, USA). All cell culturematerials were purchased
fromGIBCO and Sigma. The 5-HT2AR ligandswere supplied by Hartmann
Analitic (Braunschweig, Germany)— [3H]ketanserin, Research Biochem-
icals International (Natick,MA. USA)—methysergide, Sigma—DOI ((±)-
2,5-Dimethoxy-4-iodoamphetamine hydrochloride and butaclamol, and
Tocris— quinpirole and ketanserin. Antibodies: monoclonal mouse anti-
serotonin 5-HT2A receptors (Pharmingen), rabbit polyclonal anti-dopa-
mine D2 receptors (Santa Cruz), Alexa 488-conjugated anti-mouse IgM
(Molecular Probes), and Cy3-conjugated anti-mouse or anti-rabbit IgG
(Jackson ImmunoResearch).
2.2. Construction of fusion proteins
The human 5-HT2AR and dopamine D2R genes cloned into the
pcDNA3.1(+) plasmid were labeled with cDNA encoding enhanced
CFP (ECFP) or enhanced YFP (EYFP) by cloning into the pECFP-N1 and
pEYFP-N1 plasmids, respectively.
Brieﬂy, the full-length cDNAs encoding 5-HT2AR and D2R were
PCR-ampliﬁed. The forward primer was a universal primer for
pcDNA3.1(+) and the reverse primer removed the STOP codon and
introduced a unique restriction site, XhoI, in both receptors. The
resulting fragments were inserted, in-frame, into the NheI/XhoI sites
of the pECFP-N1 and pEYFP-N1 vectors. The obtained fusion protein
constructs were used after expression as the ﬂuorescence donor
(receptor-ECFP) or acceptor (receptor-EYFP). Henceforth, the ECFP
and EYFP variants are called CFP and YFP, respectively.
2.3. Construction of genetic variants of the serotonin and dopamine
receptors
Three genetic variants of D2R-YFP in which six amino acid residues
(two each)within the arginine-rich epitope (217RRRRKR222) of the ic3
weremutated (D2R1-YFP: 217AARRKR222, D2R2-YFP: 217AAAAKR222,
and D2R3-YFP: 217AAAAAA222) were obtained as described in our
previous study [43].Wealso constructeda genetic variant of 5-HT2A-CFP
in which the acidic epitope (454EE455) in the C-tail was mutated (5-
HT2AMUT-CFP: 454AA455). The appropriate point mutations were
generated using a QuikChange II Site-Directed Mutagenesis Kit
(Stratagene) according to the manufacturer's protocol.
Brieﬂy, the 5-HT2AR gene was inserted into the pECFP-N1 vector
and was used as the template for the PCR-Quick reaction. Incorpo-
rating the oligonucleotide primers, each complementary to the
opposite strand of the vector and containing the desired mutation,
generated a mutated plasmid. The resulting product was treated with
endonuclease DpnI to digest methylated and hemimethylated DNA
and select for the synthesized DNA containing the introduced
mutations. E.coli DH5α cells were then transformed with the mutated
plasmid. All mutated sequences were veriﬁed by DNA sequencing (IBB
PAN Warsaw, Poland).
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HEK 293 cells were grown in Dulbecco's modiﬁed essential medium
(DMEM) supplemented with 1% L-glutamine and 10% heat-inactivated
fetal bovine serum (FBS). The cells were cultured at 37 °C in an
atmosphere of 5% CO2. Transient transfections of HEK 293 cells were
performed using the calcium phosphate precipitation method, as
described by Sambrook et al. [56]. HEK 293 cells were transfected with
plasmids encoding either CFP-tagged 5-HT2AR, and 5-HT2ARMUTor YFP-
tagged 5-HT2AR, D2R, D2R1, D2R2, andD2R3 fusion proteins separately or
co-transfectedwith different combinations of both CFP- and YFP-tagged
plasmids. One day before transfection, the cells were seeded into
100 mm dishes at a density of 3×106cells/dish for ﬂuorescence spectra
measurements and binding assays. Cells were plated on glass coverslips
in 30-mm dishes at a density of 1×106cells/dish for ﬂuorescence
lifetimemeasurements and confocal imaging. The cells were transfected
with 12 μg of DNA per 100 mmdish or 2 μg of DNA per 30-mmdish. The
ratio of DNA encoding the donor to DNA encoding the acceptor was 1:1
to study homo-dimerization or 1:2 to study hetero-dimerization which
was dependent on the expression level of the investigated receptors.
Berney and Danseur [57] have shown that the most optimal to FRET
measurements is usage donor/acceptor ratio 1:1 or 1:2.
2.5. Membrane preparation and radioligand binding assay
Ligand binding experiments for 5-HT2AR were performed with and
without ﬂuorescently tagged proteins, as well as for the 5-HT2A mutant
(5-HT2AMUT-CFP). Forty-eight hours after transfection, HEK 293 cells
separately expressing the receptors were washed with phosphate-
buffered saline (PBS), scraped from the dish in PBS, and centrifuged at
200×g for 5 min. The obtained pellets were frozen at−20 °C until use.
Frozen pellets were resuspended in a 6 ml binding buffer (50 mM
Tris-HCl, pH 7.7) using an Ultra Turrax homogenizer. The homo-
genates were centrifuged twice at 25,000×g for 15 min at 4 °C. The
obtained suspension was preincubated at 37 °C for 15 min and
subsequently centrifuged at 25,000×g for 10 min at 4 °C. Then, the
pellet was resuspended in a 2 ml of the binding buffer and
homogenized. [3H]ketanserin (speciﬁc activity of 67 Ci/mmol) was
used as the 5-HT2AR-speciﬁc radioligand.
Binding assays were performed in a total volume of 400 μl.
Saturation studies were carried out on a fresh membrane preparation
(ﬁnal protein concentration of 100 μg/tube) using concentrations of
[3H]ketanserin ranging from 0.03 to 4 nM. Nonspeciﬁc binding was
assessedby the addition 50 μMmethysergide. The tubeswere incubated
for 30 min at room temperature and binding was terminated by rapid
ﬁltration through glass ﬁber ﬁlters (GF/B, Whatman). The ﬁlters were
washed three times with a 5 ml of ice-cold binding buffer and the
amount of radioactivity bound to the ﬁlter was determined by liquid
scintillation counting (WinSpectral-Wallac). Radioligand binding para-
meters, including the dissociation constant (Kd) and the maximum
binding capacity (Bmax), were estimated using the SigmaPlot 2001
version 7.0 program. Statistical analyses were performed using
Student's t-test.
Binding experiments for D2R and the genetic variants of D2R were
performed as previously described [43].
2.6. FRET measurements
Qualitative as well as quantitative methods were used to monitor
whether FRET occurs between the CFP-tagged protein (donor) and the
YFP-tagged protein (acceptor of ﬂuorescence). We used both spectro-
ﬂuorimetric measurements of cell suspensions (recorded by a
Fluorolog 3-Horiba, Jobin Yvon S.A.S., Longjumeau, France) and
measurements of FRET by ﬂuorescence lifetime microscopy and
time correlated single photon counting method (TCSPC) in a single
living cell expressing the investigated receptors in different combina-tions (performed on a Nikon Eclipse TE-2000 inverted ﬂuorescence
microscope). Each measurement was conducted 48 h after transfec-
tion at 37 °C. For each receptor combination, at least four independent
experiments were performed. During each TCSPC experiment,
ﬂuorescence decay from at least 15 cells on the coverslip was
recorded. In order to investigate the inﬂuence of speciﬁc ligands, the
cells were incubated in the presence of agonists and antagonists for
15 min at 37 °C before the measurement. Fluorescence emission
proﬁles were obtained by subtracting signals derived from both mock
transfected cells and incubated medium. This analysis was done
according to Stanasilla et al. [58]. Fluorescence intensity decays were
analyzed both as mono- and multi-exponentials. Analysis of the
reduced χ2 value and residual distribution led to the conclusion that
the best ﬁt parameters were obtained with two exponentials. Adding
a third exponential did not signiﬁcantly inﬂuence the parameters and
the fractional contribution of the additional lifetime was close to zero.
Statistical analyses were performed using Student's t-test. Detailed
information of the methodology used, along with the various control
experiments indicating the speciﬁcity of the observed effects have
been described previously [43,52,59,60]. The use of three independent
methods of FRET efﬁciency measurements (by ﬂuorescence lifetime
microscopy and confocal microscopy as well as spectroﬂuorimetric
measurements) used in our laboratory warrants the reliability of the
results [52,59]. Moreover studies of interactions of various GPCRs
(serotonin 5-HT1A, adenosine A2A, dopamine D1 and D2) with alpha
subunits of the G protein in the same transfection conditions
convincingly showed that FRET can be measured speciﬁcally only
when the given receptor is co-expressed with the appropriate
(interacting) G protein (as for example dopamine D2 and alpha-i,
but not alpha-s subunit) [43,52].
Although energy-transfer based methods are very useful tools for
studying protein–protein interactions, they have several limitations.
The interpretation of FRET efﬁciency alterations as an indication of
receptor oligomerization has been criticized. We are aware that the
effects observed in these kinds of studies may be the result of
conformational changes within the receptor molecule taggedwith the
ﬂuorescent protein. We discussed this issue in detail in our previous
paper [60]. In order to avoid misinterpretation of the data, control
experiments were conducted. The donor–acceptor distance was
calculated using the following equation:
r = R0 E
−1−1
 
1=6
h i
: ð1Þ
The anticipated possible alteration in the energy transfer induced
by the conformational change was estimated according to the
following equation (Table 3) [60–62]:
ΔE =
6r5
1 + r=R0ð Þ6
 2R60
Δr: ð2Þ
2.7. Confocal microscopy
Confocal microscopy was used to analyze the localization of the
ﬂuorescently tagged receptors in HEK 293 cells. Images were acquired
using a BioRad MRC 1024 confocal system (BioRad) interfaced with a
Nikon Diapoth 300 (Nikon) inverted microscope. The microscope was
equipped with a 60x PlanApo oil-immersion 1.4 NA objective lens and
a 100 mW argon ion air-cold laser (ITL). Detailed information has
previously been provided [43].
Image ProPlus 4.5 software was used for the co-localization
analysis. For a quantitative estimation of the degree of co-localization
between two different proteins of interest, Pearson's correlation
coefﬁcients and coefﬁcients of determination were estimated.
Pearson's correlation coefﬁcients were calculated from randomly
Fig. 1. Saturation binding of [3H]Ketanserin to human 5-HT2A receptors.Data are from a
single experiment performed in duplicate and are representative of at least three
independent experiments. Linking of the ﬂuorescent tag as well as elimination of the
acidic motif in 5-HT2AR do not signiﬁcantly alter the ligand binding constant.
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co-transfected with different combinations of the constructs (wild-
type or ﬂuorescently tagged 5-HT2AR and D2R mutants). The average
intensity of the ﬂuorescence signal was measured for every image in a
determined individual area of interest free of cells and subtracted as
background. For analysis, these regions were used for which
ﬂuorescence intensities were correlated. For each combination of
proteins, a minimum of 20 individual regions from different,
independently transfected cells were counted. Statistical analyses
were performed using Student's t-test. To make interpretations of the
Pearson's correlation coefﬁcients easier, coefﬁcients of determination
(which are squared values of the correlation coefﬁcient) were
estimated.
2.8. Immunohistochemical study
2.8.1. Tissue preparation
The rats were deeply anesthetized with sodium pentobarbital
(100 mg/kg, i.p.) and were transcardially perfused with a 0.9% NaCl,
followed by a 4% paraformaldehyde in 0.1 M phosphate-buffered
saline (PBS). After the post-ﬁxation period of 24 h, 50 μm thick
sections were cut at the level of the medial prefrontal cortex and
susbstanti nigra using a Leica VT-1000 S vibratome.
2.8.2. Immunoﬂuorescence staining
Free-ﬂoating sections from medial prefrontal cortex and substan-
tia nigra were developed using immunoﬂuorescence double-labeling
protocols to determine the co-localization of serotonin 5-HT2A and
dopamine D2 receptors. The sections were incubated in a blocking
buffer (5% normal donkey serum and 0.3% Triton X-100 in 0.01 M PBS)
for 1 h. Next, the sections were incubated (48 h at 4 °C) with primary
antibodies: monoclonal mouse anti-serotonin 5-HT2A receptors
antibody (1:200) and rabbit polyclonal anti-dopamine D2 receptors
(1:100). The speciﬁcity of anti-D2 receptors antibodies has been
demonstrated by Park [63] and Kovoor [64].
Antibodieswere diluted in 5% normal donkey serum and 0.3% Triton
X-100 in 0.01 M PBS. The sections were then washed and incubated
overnight (4 °C) in a mixture of secondary antibodies: Alexa 488-
conjugated anti-mouse IgM (1:200) for serotonin 5-HT2A receptors and
Cy3-conjugated anti-mouse or anti-rabbit IgG (1:300) for dopamine D2
receptors. Sections were then washed, mounted, and coverslipped.
Slices were analyzed with a confocal laser scanning microscope,
DMRXA2 TCS SP2 (Leica), using a 63×/1.4−0.7 oil objective (Leica)
driven by a confocal software (Leica) using sequential scan settings.
Working with argon and GreNe lasers, two laser lines emitting at 488
and 543 nmwere used for exciting the Alexa 488- and Cy3-conjugated
antibodies, respectively. The background noise of each confocal image
was then reduced by averaging four scans/line and six frames/image.
The pinhole value of one airywas used in order to obtainﬂat images (for
further details [65,66]).
3. Results
3.1. Radioligand binding assay
We previously showed that the binding parameters obtained for
D2R and its mutants (D2R1, D2R2) displayed similar Kd values [43]. The
D2R3 (217AAAAAA222) variant localizedwithin the cell; therefore, no
binding parameters could be established for this mutant protein.
Binding experiments (Fig. 1) conducted for wild-type 5-HT2AR, as well
as ﬂuorescently labeled 5-HT2AR indicate that the Kd values for these
two receptors are similar (Table 1). These data show that the
ﬂuorescent tag does not cause changes in the ligand binding
properties of these receptors. Moreover, similar binding parameters
were obtained for CFP-tagged 5-HT2AMUT (Table 1).Additional binding assays were performed for cells co-expressing
both 5-HT2AR and D2R3. Saturation analysis was performed with [3H]
spiperone for D2R points to a negligible level of binding (data not
shown). In this case, although D2R3 seems to be present within the
plasma membrane, it is not functional.3.2. Analysis of the localization of 5-HT2AR, D2R and their genetic variant
fusion proteins
Confocal microscopy was used to visualize and analyze the
localization of 5-HT2AR and D2R as well as their genetic variants (5-
HT2AMUT, D2R1, D2R2, D2R3) in HEK 293 cells. These experiments
demonstrate the inﬂuence of the introduced mutations on the
subcellular localization of the receptor proteins. Fig. 2A shows HEK
293 cells transiently co-transfected with 5-HT2AR and 5-HT2AMUT, as
well as D2R, D2R1, D2R2 and D2R3, in different combinations. The green
signal (CFP channel) results from receptors expressingCFPwhile the red
signal (YFP channel) is from receptors tagged with YFP. Merged images
(with apparent yellow signal indicating overlap of the green and the red
signal) indicate co-localization. Additionally, Pearson's correlation
Table 1
Binding parameters for the serotonin 5-HT2A receptors.
Species Bmax (pmol/mg protein) Kd (nM)
5-HT2A 1.61 (±0.23) 1.43 (±0.07)
5-HT2A_CFP 1.10⁎ (±0.16) 1.34 (±0.06)
5-HT2A MUT_CFP 0.82⁎ (±0.18) 0.95 (±0.24)
The standard errors of means are presented in parentheses, n=5. The statistical
signiﬁcance was evaluated using Student t-test.
⁎ pb0.05 vs 5-HT2A.
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determine the degree of co-localization of the receptors (Fig. 2B).
As seen in Fig. 2, 5-HT2AR localized mainly in the cell membrane and
introductionofmutationswithin theC-tail of the receptor did not change
the subcellular distribution of 5-HT2AR. In cells concomitantly expressing
5-HT2AR and D2R, these receptors not only localized to the plasma
membrane, butwere also foundwithin the cell. Cells co-transfectedwith
both wild-type and genetic variants of 5-HT2AR (5-HT2AMUT-CFP/5-
HT2A-YFP) as well as with 5-HT2AR and one of the variants of D2R (in the
following combinations: 5-HT2A-CFP/D2-YFP, 5-HT2A-CFP/D2R1-YFP, 5-
HT2A-CFP/D2R2-YFP, and 5-HT2A-MUTCFP/D2-YFP), the obtained values
of both Pearson's correlation coefﬁcients and coefﬁcients of determina-
tion remained approximated. On the other hand, cells co-expressing 5-Fig. 2. Expression of 5-HT2AR and D2R and their mutants in HEK 293 cells.(A) HEK 293 cells we
D2R2-YFP, D2R3-YFP or 5-HT2A-YFP (green and red). Image overlays show extensive co-loca
D2R1, 5-HT2A/D2R2 assays and partial co-localization in 5-HT2A/D2R3 assays. (B) Bar graph of
serotonin 5-HT2A and dopamine D2 receptor protein construct combination. Data are mean±
combinations 5-HT2A with D2R3 variant vs 5-HT2A/D2. Either 5-HT2AMUT/D2 and 5-HT2A/D2R
not statistically signiﬁcant. Values of corresponding coefﬁcients of determination (r2) are repHT2AR and the D2R3 mutant displayed a decrease in the degree of co-
localization, which correlated with the replacement of all amino acid
residues within the ic3 (217–222) of D2R.3.3. Fluorescence spectroscopy measurements of 5-HT2AR and D2R
dimerization
Steady state ﬂuorescence spectroscopy measurements in cell
suspension allow for a quick estimation of whether there is any energy
transfer in the examined sample. However, this is only a qualitative
approach, but at the same time is very demonstrative. Therefore, we
used this type ofmeasurement to investigate the interaction between5-
HT2AR and D2R and their genetic variants. Fig. 3 shows the ﬂuorescence
emission spectra for HEK 293 cell suspensions co-expressing the fusion
proteins in different combinations (5-HT2A-CFP/D2-YFP, 5-HT2A-CFP/
D2R1-YFP, 5-HT2A-CFP/D2R2-YFP, 5-HT2A-CFP/D2R3-YFP, 5-HT2AMUT-
CFP/D2-YFP, 5-HT2A-CFP/5-HT2A-YFP and 5-HT2AMUT-CFP/5-HT2A-
YFP) after excitation at 434 nm (donor absorption).
Results presented in Fig. 3A show representative emission spectra
of the HEK 293 cell populations co-expressing 5-HT2AR and D2R fusion
proteins (5-HT2A-CFP and D2-YFP) in comparison to the emission
spectra of cell populations co-expressing the 5-HT2AR fusion protein
(5-HT2A-CFP) and one of the genetic variants of the D2R fusion protein
(D2R1, D2R2 or D2R3-YFP). Fig. 3B shows the ﬂuorescence emissionre co-transfected with either 5-HT2A-CFP or 5-HT2AMUT-CFP and either D2-YFP, D2R1-YFP,
lization in 5-HT2A/5-HT2A, 5-HT2AMUT/5-HT2A, 5-HT2A/D2, 5-HT2AMUT/D2 and 5-HT2A/
Pearson's correlation coefﬁcient calculated for HEK 293 cells co-transfected with different
SE, and statistical signiﬁcance was evaluated using Student's t-test. *pb0.05 n=20 for
1, 5-HT2A/D2R2 vs 5-HT2A/D2 or 5-HT2AMUT/5-HT2A vs 5-HT2A/5-HT2A combinations are
orted in brackets.
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HT2AMUT-CFP) and D2R (D2-YFP) in relation to the spectra obtained
for cells co-expressing the wild-type forms of these receptors.Energy transfer (judged by the localization of the appropriate peaks
of the spectra) occurred in each combination tested. However, when
either the genetic variant of 5-HT2AR (5-HT2AMUT) or the D2R3 genetic
variant of D2R was present in the sample, the level of FRET was lower.
Efﬁcient energy transfer was observed in spectra obtained fromHEK
293 cells expressing 5-HT2AR tagged with either CFP or YFP (Fig. 3C).
Efﬁcient energy transfer was also obtained from cells expressing the 5-
HT2AR mutant (5-HT2AMUT-CFP) instead of the wild-type 5-HT2AR.
Fluorescence emission proﬁles derived from a mixture of two HEK
293 cell populations (one transfected with only the plasmid encoding
the receptor-CFP fusion protein and the second transfected with the
plasmid encoding the receptor-YFP fusion protein) were obtained as a
negative control for this experiment. Although both ﬂuorophores were
present in the sample, no visible energy transfer after excitation at
434 nm was observed. The shape of the recorded spectra was the same
as inHEK293cells expressing the receptors separately (datanot shown).3.4. Fluorescence lifetime microscopy studies of serotonin 5-HT2A and
dopamine D2 receptor dimerization
Fluorescence lifetime microscopy measurements exploiting the
time-correlated single photon counting (TCSPC) technique provide
highly quantiﬁable data because it is independent of any change in the
ﬂuorophore concentration or excitation intensity. Moreover, FRET can
be observed in a single living cell. In the present study, the cell is
transiently transfected with 5-HT2AR and D2R, as well as their genetic
variants, tagged with ﬂuorescent proteins in different combinations.
To estimate FRET efﬁciency, precise measurement of the donor
ﬂuorescence (CFP) lifetime in the presence and absence of the
acceptor (YFP) is required. The typical time-dependent donor
intensity decays for 5-HT2AR-CFP bearing donor alone and with both
the donor and the acceptor, 5-HT2AR-CFP/D2R-YFP, are presented in
Fig. 4. The value of the average donor ﬂuorescence lifetime changed
when the acceptor was additionally present in the cell. The greatest
average ﬂuorescence lifetime decrease, regarded as the highest FRET
efﬁciency (approximately 36%), was detected by this approach in our
previous studies using the CFP–YFP hybrid (CFP connected by a short
15 amino acid linker with YFP) [52,59]. Additionally, some control
experiments were conducted. We measured the ﬂuorescence lifetime
of CFP expressed in the cells alone or together with YFP — when cells
were loaded with both ﬂuorescent proteins, not linked to any
receptors, no FRET was observed, despite their high expression and
localization in the cytoplasm (Table 2).
The average CFP ﬂuorescence lifetime estimated in cells expressing
5-HT2AR-CFP or its genetic variant 5-HT2AMUT-CFP was 2.31 ns and
2.33 ns, respectively. When both ﬂuorophores (receptor-CFP, recep-
tor-YFP) were present in the cell, a shortening of the average donor
lifetime was observed. The value of the energy transfer efﬁciency was
about 9.0% (average donor ﬂuorescence lifetime of 2.10 ns) when
measurements were performed in cells co-expressing 5-HT2AR-CFP
and D2R-YFP fusion proteins. Replacing D2R with genetic variants
(D2R1, D2R2 or D2R3-YFP, respectively) resulted in a change in the
value of the energy transfer efﬁciency. For the combination of 5-HT2AR
and D2R1, the energy transfer efﬁciency was equal to 4.3% (2.21 ns)Fig. 3. Fluorescence emission spectra of HEK 293 cells expressing the CFP- and YFP-tagged
proteins coupled to 5-HT2AR and D2R and their mutants.(A) Co-transfection of HEK 293
with 5-HT2A-CFP and either D2-YFP (black solid line), D2R1-YFP (black dashed line), or
D2R2-YFP (black dotted line) or D2R3-YFP (dark grey solid line). (B) Co-transfection of
HEK 293 with 5-HT2AMUT-CFP and D2-YFP (dark grey solid line) in comparison
with 5-HT2A-CFP and D2-YFP (black solid line). (C) Co-transfection of HEK
293 with 5-HT2AMUT-CFP and 5-HT2A-YFP (dark grey solid line) in comparison
with 5-HT2A-CFP and 5-HT2A-YFP (black solid line). CFP was excited at 434 nm, and
ﬂuorescence was detected at 450–550 nm through a double monochromator. The
spectral contributions arising from light scattering and non-speciﬁc ﬂuorescence of
cells and buffer were eliminated.
Fig. 4. Time-dependent ﬂuorescence intensity decays of CFP attached to the 5-HT2A
receptor with and without YFP attached to the D2 receptor.The dark grey dotted curve
shows the intensity decay of the donor alone (D), and black dotted curve shows the
intensity decay of the donor in the presence of acceptor (DA). The dark grey (D) and
black (DA) solid lines and weighted residuals (lower panels) are for the best double
exponential ﬁts. The grey crosshair curve represents the excitation pulse diode laser
proﬁle, set up at 434 nm.
Table 2
Summary of energy transfer measurements by ﬂuorescence lifetime microscopy in HEK
293 cells.
Species Average lifetime [ns] Transfer
efﬁciency
〈E〉 (%)
〈τD〉 〈τDA〉
aCFP 2.36 (±0.02)
bCFP+YFP 2.35 (±0.02)
cCFP-YFP 1.52 (±0.03) 35.8 (±1.38)
d5-HT2A_CFP 2.31 (±0.01)
e5-HT2A_CFP/D2_YFP 2.10 (±0.01) 9.09 (±0.59)
f5-HT2A_CFP/D2R1_YFP 2.21 (±0.02)⁎ 4.33 (±0.96)
g5-HT2A_CFP/D2R2_YFP 2.23 (±0.01)⁎ 3.46 (±0.60)
h5-HT2A_CFP/D2R3_YFP 2.26 (±0.01)⁎ 2.16 (±0.61)
i5-HT2A MUT_CFP 2.33 (±0.02)
j5-HT2A MUT_CFP/D2_YFP 2.27 (±0.02)* 2.58 (±1.20)
k5-HT2A_CFP/5-HT2A_YFP 2.07 (±0.01) 10.39 (±0.88)
l5-HT2A MUT_CFP/5-HT2A_YFP 2.09 (±0.01) 10.30 (±0.88)
Excitation was set up at 434 nm, and emission was observed through the appropriate
interference ﬁlters, as described in the Experimental Procedures. The standard errors of
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HT2AR and D2R2 combination. The energy transfer efﬁciency was 2.2%
(2.26 ns) for the combination of 5-HT2AR and D2R3. Similarly, when
the 5-HT2AR genetic variant (5-HT2AMUT) was used instead of the
wild-type 5-HT2AR (speciﬁcally, the combination of 5-HT2AMUT and
D2R), a 2.6% (2.27 ns) decrease in the energy transfer efﬁciency was
observed.
Measurement of the cells co-expressing the same type of receptor (5-
HT2AR) tagged with both ﬂuorescent proteins (CFP and YFP) indicates a
more than 10% energy transfer efﬁciency with an average lifetime
2.07 ns. Moreover, the replacement of 5-HT2AR with 5-HT2AMUT did not
signiﬁcantly change the value of the energy transfer (10.3%, 2.09 ns).
A summary of the TCSPC results is presented in Table 2. The error
of the average ﬂuorescence lifetime is the standard error of the mean
obtained from different cells and independent transfections (standard
deviations derived from ﬁtting the individual ﬂuorescence decaywere
ignored because they were very small).means are presented in parentheses. Statistical signiﬁcance was evaluated using
Student t-test; n=53–62.
a Measured in cell expressing CFP not linked to any receptors.
b Measured in cell co-expressing CFP and YFP not linked to any receptors.
c Measured in cell expressing CFP-YFP hybrid.
d Measured in cell expressing CFP coupled to the serotonin 5-HT2A receptor.
e Measured in cell co-expressing the serotonin 5-HT2A and dopamine D2 fusion
proteins (5-HT2A-CFP and D2-YFP).
f Measured in cell co-expressing the serotonin 5-HT2A and genetic variant of
dopamine D2 fusion proteins (5-HT2A-CFP and D2R1-YFP).
g Measured in cell co-expressing the serotonin 5-HT2A and genetic variant of
dopamine D2 fusion protein (5-HT2A-CFP and D2R2-YFP).
h Measured in cell co-expressing the serotonin 5-HT2A and genetic variant of
dopamine D2 fusion proteins (5-HT2A-CFP and D2R3-YFP).
i Measured in cell expressing CFP coupled to the genetic variant of serotonin 5-HT2AMUT
receptor.
j Measured in cell co-expressing genetic variant of the serotonin 5-HT2A and
dopamine D2 fusion proteins (5-HT2AMUT-CFP and D2-YFP).
k Measured in cell co-expressing two serotonin 5-HT2A receptor fusion proteins
(5-HT2A-CFP and 5-HT2A-YFP).
l Measured in cell co-expressing the serotonin 5-HT2A receptor and genetic variant of
the serotonin 5-HT2A receptor fusion protein (5-HT2AMUT-CFP and 5-HT2A-YFP).
⁎ pb0.05 vs. 5-HT2A-CFP/D2-YFP.3.5. The inﬂuence of speciﬁc ligands on dimerization processes—ﬂuorescence
lifetime microscopy studies
Next, we examined the effect of typical agonists (DOI and quinpirol)
and antagonists (ketanserin and butaclamol) on dimerization processes
of 5-HT2AR and D2R. FRET efﬁciency values estimated for each receptor
combination changed after the addition of the selective ligands to the
incubation medium. In the case of homo-complexes of 5-HT2AR, DOI
caused an increase in the energy transfer efﬁciency to the level of 12%
(2.03±0.02 ns).When the antagonist ketanserinwas added, a decrease
in the basal transfer efﬁciency value to 4.3% (2.21±0.03 ns) was
observed. In the 5-HT2AR and D2R combinations, both the selective 5-
HT2AR and the selective D2R agonists (DOI and quinpirol, respectively)
caused a decrease in the FRET value (6.5%, (2.16±0.01 ns) and 6% (2.17
±0.02 ns), respectively). Meanwhile, the selective antagonists (ketan-
serin and butaclamol) increased the transfer efﬁciency value (11.6%
(2.04±0.02 ns) and 11.3% (2.05±0.02 ns), respectively; Fig. 5).Additional control experiments were conducted to prove that the
observed alterations in the FRET efﬁciency were not the result of
conformational changes (within the receptors) as a consequence of
ligand binding. The distance of the donor–acceptor pair (r) for the
investigated receptor combinations, as well as possible alterations in
energy transfer (ΔE) due to the above-mentioned effect, was
estimated (Table 3). Moreover, the average donor ﬂuorescence
lifetime for cells expressing only CFP-tagged receptors in the presence
of the speciﬁc ligands used in this study were recorded. Estimated
values were from 2.29±0.03 to 2.31±0.01 ns. The obtained data
indicate that the observed alterations in the FRET efﬁciency are not
due to the reorientation of the ﬂuorescence donor or differences of its
quantum yield.3.6. Immunohistochemical study
In the medial prefrontal cortex serotonin 5-HT2A receptors have
been observed in neurons which by size and shape should be deﬁned
as a pyramidal one. 5-HT2A serotonin receptors were also observed in
dendritic shafts (Fig. 6A). Dopamine D2 receptor proteins have been
observed mainly in the cell bodies, however rare dopamine positive
dendritic processes were observed (Fig. 6A). Different pattern of
labeling has been observed in pars reticulate of the substantia nigra
(Fig. 6B). Both antigens stain the periphery of the neuronal cell bodies,
dendrites emanating or not related to the cell bodies of neurons,
which by size and shape might be considered dopaminergic ones.
Fig. 5. Bar graph of FRET efﬁciency values estimated for combination of homo-dimers 5-HT2A/5-HT2A and hetero-dimers 5-HT2A/D2 after stimulation by DOI, ketanserin, quinpirol and
butaclamol, respectively.Values in bracket reﬂect the standard errors of means. The statistical signiﬁcance was evaluated using Student t-test *pb0.05 vs 5-HT2A/5-HT2A or 5-HT2A/D2,
respectively; n=57–65.
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mine D2 receptors has been observed in both the medial prefrontal
cortex and substantia nigra.Table 3
The anticipated possible alteration in energy transfer induced by the conformational
change.
5-HT2A/D2 5-HT2A/5-HT2A
r [nm] 7.20 7.02
ΔE [%] 1.37 1.59
The values were estimated according to the Eqs. (1), and (2).4. Discusion
Membrane-bound proteins, such as tyrosine kinases, cytokines or
transforming growth factor receptors, have been known for many
years to exist and been active in an oligomeric form. In contrast, the
possibility of GPCRs associations has only recently been widely
accepted. Therefore, the molecular details of GPCRs oligomerization
processes are still poorly understood. Although many GPCRs have
been shown to undergo homo- or hetero-dimerization [1,3,4] either in
response to ligand or constitutive [27,52,59,67,68], little is known
about the mechanisms involved in the association of these proteins.
In the present study, constitutive dimerization (either homo- or
hetero-) between 5-HT2AR and D2R was investigated in living HEK 293
cells using biophysical approaches (spectroﬂuorimetric measurements
and ﬂuorescence lifetime measurements) based on FRET. FRET is a
technique widely used to monitor protein–protein interactions [53,54]
and allows for the observation of the physical proximity between
molecules by assessing the level of energy transfer occurring between
the energy donor and the acceptor (in this study receptor-CFP and
receptor-YFP, respectively). In order to monitor energy transfer between
investigated proteins, we co-expressed the fusion proteins in HEK 293
cells in different combinations. Generally, GPCRs oligomerization is
difﬁcult to analyze in native cells. The HEK cell line has been widely
used in resonance energy transfer studies of membrane receptors,
because these cells provide an accepted model in which ﬂuorescently
tagged receptor proteins can be efﬁciently expressed. The often discussed
problem connected with experiments performed in heterologous
expression systems is the issue concerning “overcrowding” of the proteinof interest [69]. Meaning, GPCRs dimerization might simply be promoted
at relatively highexpression levels andmaypartially be anartifact of over-
expression. However, studies indicate that the extent of dimerization of
the receptors (shown by bioluminescence resonance energy transfer
(BRET))was unchangedover a 20-fold range of expression level of theβ2-
adrenergic receptor (from 1.4 to 26.3 pmol/mg protein). [70]. Addition-
ally, while studying the homo-dimerization of neuropeptide Y receptors,
the FRET effect was demonstrated to be independent of the level of
receptor expression [71]. Similarly, β2/β3-adrenergic hetero-dimers
possessed a stable BRET signal for expression levels ranging from 0.58
to 6.5 pmol/mg protein [22]. In the present study, the experiments were
conductedwith reasonable expression levels of the investigated receptors
(ranging from 0.82 to 1.61 pmol/mg protein). These ﬁndings imply that
examples of the observed GPCRs dimerization are not merely an artifact
derived from the high level of expression achieved in a heterologous
system. Moreover, data obtained in our previous studies [43,52]
concerning the interactions between the GPCRs (D1R, D2R and 5-HT1AR)
and the appropriate α subunit of G protein conﬁrm the speciﬁcity of the
methodology (FRET measurements by ﬂuorescence spectroscopy and
ﬂuorescence lifetimes) used herein. Using the same expression system
and the same amount of DNA for transient transfections, FRET did not
occur when two non-interacting fusion proteins (bearing CFP and YFP,
respectively) were co-expressed in the same cell. Moreover, using this
Fig. 6. Representative images (confocal laser scanning microscopy) illustrating
colocalization of serotonin 5-HT2A (green), dopamine D2 receptors (red) in rat medial
prefrontal cortex (A) and pars reticulate of substantia nigra (B). Asterisk-points to the
neuronal cell bodies positive for both antigens, arrows-dendritic processes. White
arrow head in A — dendritic shafts of pyramidal neurons; black arrow head in A — cell
body of neuron positive for dopamine D2 receptors and negative for serotonin 5-HT2A
receptors. Scale bars in A and B 20 μm.
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the expression of one of the studied receptors was decreased [72].
Therefore, we conclude that the observed effects reﬂect a speciﬁc
interaction and are not the result of over-expression of the studied
receptors.
In the present study, we demonstrate for the ﬁrst time (using both
ﬂuorescence spectroscopy and ﬂuorescence lifetime microscopy to
determine FRET efﬁciency) that 5-HT2AR and D2R form dimers. In
addition, the data obtained in this work indicate that 5-HT2AR forms
homo-dimers. These data provide the ﬁrst evidence that 5-HT2AR/D2R
and 5-HT2AR/5-HT2AR complexes may exist in living cells.
D2R and 5-HT2AR display complex interactions during neurotrans-
mission [48,49]. The afﬁnity of second-generation antipsychotic drugs
for both D2R and 5-HT2AR is strongly postulated as the mechanism of
action of these drugs [51]. Therefore, a detailed understanding of the
dimerization process of these receptors is essential. Various studies
suggest that GPCRs hetero-dimers form functional complexes with
distinct drug speciﬁcities and signaling properties, in which each
individual receptor subunit may be responsible for a speciﬁc function
[73–77]. Recently, the importance of a 5-HT2R and metabotropic
glutamate subtype 5 (mGluR5) receptor complex has been implicated
in psychosis [78].
The physical interaction between two receptors can take place
only if they are concomitantly expressed in the same cell. In the brain,
co-expression of 5-HT2AR and D2R has been shown at least in
dopaminergic cells in the ventral tegmental area [79,80]. Another
potential site for a direct 5-HT2AR/D2R interaction is layer V of the
prefrontal cortex [50,81].
In thepresentwork–using the immunoﬂuorescencedouble labeling
protocols –we show the data indicating the colocalization of serotonin
5-HT2A and dopamine D2 receptors in the medial prefrontal cortex as
well as in the pars reticulate of substantia nigra of the rat brain.
Both of these brain receptors have been implicated as important
sites of action of antipsychotics due to a well-documented serotonin–
dopamine interaction and its relevance to schizophrenia [49]. The 5-
HT2AR/D2R complexmay be a potential target for more novel effective
therapeutics. In this context, it seems very important to estimate the
inﬂuence of 5-HT2AR- and D2R-speciﬁc ligands on the dimerization
process. Typical 5-HT2AR (DOI and ketanserin) and D2R (quinpirol and
butaclamol) ligands display distinct actions depending on the receptor
combination. In the case of 5-HT2AR homo-dimers, the agonist DOI
increased the level of FRET efﬁciency, while the antagonist ketanserin
decreased the basal energy transfer value. A similar effect was recorded
in our previous study on homo-dimers of 5-HT1AR and the adenosine
A2A receptors [52]. Opposite effects were observed when we investi-gated the inﬂuence of ligands on hetero-complexes of 5-HT2AR andD2R.
Agonists (DOI and quinpirol) decreased the FRET value while
antagonists (ketanserin and butaclamol) increased the FRET value. As
a result of analyzing these data, the proportion of the monomeric and
oligomeric forms of the receptors on the cell membrane still requires
resolution. Homo- and hetero-dimers of the investigated receptors are
likely to be formed simultaneously. In the present study, we could not
distinguish homo-dimers because the homo-complexes would be built
with receptors tagged with the same ﬂuorescent protein. The presence
of 5-HT2AR andD2Rhomo-dimersmost likely inﬂuenced theeffect of the
ligands. Therefore, the observed effects might be the result of the
promotion of homo-dimerization over hetero-dimerization after treat-
ment with speciﬁc agonists. Hence, a lower level of FRET efﬁciency was
detected. Similarly, the addition of antagonists weakened homo-
dimerization, in turn causing an increase in energy transfer from the
hetero-dimer combination. Promotion of homo-dimerization over
hetero-dimerization has been previously described for D2R and the
adenosine A2A receptors [82].
Generally, transmembrane domains and hydrophobic interactions
are considered the most effective and probable elements engaged in
the GPCR family dimerization process [36,83,84]. However, partici-
pation of the C-terminal, the N-terminal and the ic3 regions are also
documented [26,28,44]. Previous work suggests that heteromeriza-
tion involves noncovalent interaction, and in this particular case, the
noncovalent bond has been proven to be even more stable than a
covalent one [47]. Noncovalent interactions seem to be more effective
[67,85–87]. Stable noncovalent complexes betweenpeptidesmight form
through electrostatic interactions between cationic guanidinium groups
(located at the terminus of the arginine side chain) and the anionic
carboxyl groups of aspartate or glutamate and/or anionic phosphate
group on phosphorylated residue [40,42,88,89]. Motifs composed of a
minimumof twoadjacent arginine residues “RR”or “RKR”ononepeptide
and two adjacent aspartate “DD” or glutamate “EE” or/and one
phosphorylated residue (usually a serine residue) in close proximity to
one another have been shown to be sufﬁcient to generate stable
noncovalent complexes between these two peptides [46,47,89].
Various reports suggest that the mechanisms involved in hetero-
dimerization of some GPCRs are connected to the presence of the
motifs described above and the formation of salt bridges
[20,40,45,90]. For instance, Ciruela et al. [44] used pull-down assays
and mass spectrometry to postulate that hetero-dimerization of the
adenosine A2A receptor and D2R strongly depends on electrostatic
interactions between the Arg-rich epitope within the ic3 of D2R and
the acidic epitope in the C-tail of the adenosine A2A receptor. This
interaction between the ic3 and the C-tail is also described by Lee et al.
[45] for D2R and the cannabinoid CB1 receptor. In addition, Woods et
al. [40,41] described a similar interaction between the glutamate
NMDA (NR1 subunit) receptor and D1R.
In our previous study (using FRET methodology), we showed that
D1R and D2R dimerize [43,59]. Additionally, experiments conducted
with the use of site-directed mutagenesis indicated the role of speciﬁc
regions in the dopamine receptor in the hetero-dimerization process.
Both the Arg-rich epitope from the ic3 of D2R and the acidic epitope
within the C-terminus of D1Rwere engaged during hetero-association
of these proteins and had no inﬂuence on homo-dimerization [43].
Due to the presence of a similar acidic motif (consisting of two
glutamate residues, 454EE455) within 5-HT2AR, we wanted to
determine its role in homo- or hetero-(with D2R) dimerization.
The residues located within the ic3 and the C-terminal tail have
opposite charges, allowing for the formation of salt bridges between
the epitopes. As a result of replacing the Arg residues in the ic3 with
Ala, the level of FRET decreased in HEK cells co-expressing 5-HT2AR
and one of the genetic variants of D2R. The degree of 5-HT2AR/D2R
hetero-dimerization depended on the number of exchanged residues
within the ic3 (217–222) of D2R. The efﬁciency of energy transfer
estimated for wild-type 5-HT2AR/D2R hetero-dimers was reduced by
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of 5-HT2AR and D2R1). Replacement of the two additional Arg residues
in that region (combination of 5-HT2AR and D2R2) caused a further
decrease in the FRET efﬁciency to approximately 20%.When the entire
basic region (217–222) of D2R contained Ala residues, the lowest level
of energy transfer was observed (2.2%; combination of 5-HT2AR and
D2R3). A similar value of energy transfer (2.6%) was obtained after
replacement of the two acidic glutamate residues in the C-tail of 5-
HT2AR. These results suggest that the basic region of the ic3 of D2R and
acidic region of the C-tail of 5-HT2AR are involved in the association
between these two receptors.
However, a different conclusion is drawn on the role of the acidic
epitope (from the C-tail of 5-HT2AR) in the homo-dimerization of 5-
HT2AR. Our data suggest that the acidic epitope does not participate in
the formation of homo-complexes between 5-HT2AR. Both qualitative
estimations of FRET by ﬂuorescence spectroscopy measurements in a
cell suspension as well as quantitative measurements of ﬂuorescence
lifetimes in a single living cell co-expressing serotonin receptors
(wild-type and the genetic variant 5-HT2AMUT (454AA455)) yield the
same results. Keeping in mind the nature of electrostatic interactions,
the conclusion that the acidic epitope is not involved in the homo-
dimerization of 5-HT2AR appears to be justiﬁed, especially since both
receptors within the homo-complex possess the samemotifs with the
same charge. A similar effect was observed in our previous study
when the role of the amino acids residues from either the C-tail
(404EE405) of D1R or the ic3 (217RRRRKR222) of D2R in homo-dimer
formation was investigated [43].
Even advanced biophysical techniques cannot solely be used in the
studies of receptor oligomerization, especially when speciﬁc sequence
motifs responsible for membrane protein dimerization are investi-
gated. Therefore, we examined using confocal microscopy the
subcellular localization of 5-HT2AR and D2R as well as their genetic
variant fusion proteins. Results obtained from cells co-expressing only
the serotonin receptors show the same cell surface localization of both
the wild-type and the mutant receptors. Thus, the glutamate residues
in the C-tail of 5-HT2AR have no inﬂuence on membrane expression of
5-HT2AR. In cells co-expressing different types of these receptors (5-
HT2AR and D2R), the distribution of 5-HT2AR was changed. In addition
to being localized on the cell surface, a considerable portion of the
receptor was also present inside the cell. We previously observed a
similar situation [43] for D1R and D2R. Moreover, experiments
conducted by So et al. [91] show that when expressed alone, D1R
and D2R localize to different regions of the cell. D1R was found
predominantly on the cell surface, whereas D2R localized at the cell
surface but was also found intracellularly. Simultaneous synthesis of
both dopamine receptors induced alterations in the cellular distribu-
tion of these proteins, causing them to be localized either on the cell
surface or in intracellular compartments [91]. These observations may
explain an increase in the cellular localization of 5-HT2AR in the
presence of simultaneous expression of D2R.
In conclusion, the data presented herein, obtained using method-
ology based on FRET as an analytical tool, demonstrate that hetero-
dimerization of 5-HT2AR and D2R results from an interaction between
speciﬁc motifs in the two receptors (454EE455 in 5-HT2AR and 217–
222 in D2R). Although the data obtained for combinations involving
the D2R3 mutant may be considered controversial (in this case, a
decrease in FRET efﬁciency may be connected with a decrease in
receptor membrane density or misfolding of the receptor and hence
the receptor is unable to interact with 5-HT2AR), the data obtained for
the 5-HT2AR/D2R1 and the 5-HT2AR/D2R2 combinations clearly
indicate the key role for the ic3 region in the dimerization of 5-
HT2AR and D2R. However, this region does not seem to be the only
point of contact between these receptors and another type of
interactions may also be engaged during this process. On the other
hand, the acidicmotif locatedwithin 5-HT2AR has no signiﬁcant role in
homo-dimerization of 5-HT2AR. Similar to what we have shownpreviously for D1R/D2R interactions, the current study indicates the
importance of simultaneous use of both well controlled biophysical
methodology together with monitoring of the subcellular localization
of 5-HT2AR and D2R and their genetic variants. Further detailed
description of the action of speciﬁc ligands on receptor dimer
complexes may have an impact on our understanding of the
mechanism by which distinct signaling pathways are directly linked
and receptor function is integrated. This information may have
therapeutic implications for several human diseases. It is especially
important in light of the data provided in the present work, showing
the presence of serotonin 5-HT2A and dopamine D2 receptors in the
same neuronal cells in the rat brain.
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